Literature DB >> 19499421

Cognitive functioning in bipolar and co-occurring substance use disorders: a missing piece of the puzzle.

Boaz Levy1, Roger D Weiss.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19499421      PMCID： PMC3150554          DOI： 10.1080/10673220902979870

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN： 1067-3229            Impact factor:   3.732


× No keyword cloud information.
  29 in total

Review 1.  The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review.

Authors:  C E Bearden; K M Hoffman; T D Cannon
Journal:  Bipolar Disord       Date:  2001-06       Impact factor: 6.744

2.  Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome.

Authors:  A Martínez-Arán; R Penadés; E Vieta; F Colom; M Reinares; A Benabarre; M Salamero; C Gastó
Journal:  Psychother Psychosom       Date:  2002 Jan-Feb       Impact factor: 17.659

3.  The clinical epidemiology of pure and mixed manic episodes.

Authors:  F Cassidy; B J Carroll
Journal:  Bipolar Disord       Date:  2001-02       Impact factor: 6.744

4.  The impact of substance abuse on the course of bipolar disorder.

Authors:  S M Strakowski; M P DelBello; D E Fleck; S Arndt
Journal:  Biol Psychiatry       Date:  2000-09-15       Impact factor: 13.382

5.  Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.

Authors:  A Martínez-Arán; E Vieta; F Colom; C Torrent; J Sánchez-Moreno; M Reinares; A Benabarre; J M Goikolea; E Brugué; C Daban; M Salamero
Journal:  Bipolar Disord       Date:  2004-06       Impact factor: 6.744

6.  Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder.

Authors:  Stuart Watson; Peter Gallagher; James C Ritchie; I Nicol Ferrier; Allan H Young
Journal:  Br J Psychiatry       Date:  2004-06       Impact factor: 9.319

Review 7.  The bipolar patient with comorbid substance use disorder: recognition and management.

Authors:  Mark J Albanese; Ronald Pies
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

8.  Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.

Authors:  Anabel Martínez-Arán; Eduard Vieta; María Reinares; Francesc Colom; Carla Torrent; Jose Sánchez-Moreno; Antonio Benabarre; José Manuel Goikolea; Mercè Comes; Manel Salamero
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

9.  Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation.

Authors:  Ihsan M Salloum; Jack R Cornelius; Juan E Mezzich; Levent Kirisci
Journal:  Bipolar Disord       Date:  2002-12       Impact factor: 6.744

10.  Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care.

Authors:  Boaz Levy; Benedetta A Monzani; Matthew R Stephansky; Roger D Weiss
Journal:  Psychiatry Res       Date:  2008-08-27       Impact factor: 3.222
View more
  4 in total

Review 1.  Bipolar Depression and Cognitive Impairment: Shared Mechanisms and New Treatment Avenues.

Authors:  Colin A Depp; Sheena Dev; Lisa T Eyler
Journal:  Psychiatr Clin North Am       Date:  2015-12-11

2.  Cognitive impairment in individuals with bipolar disorder with and without comorbid alcohol and/or cocaine use disorders.

Authors:  Chengxi Li; Jayme M Palka; E Sherwood Brown
Journal:  J Affect Disord       Date:  2020-04-29       Impact factor: 4.839

3.  Cognitive functioning in patients with bipolar disorder: association with depressive symptoms and alcohol use.

Authors:  Marieke J van der Werf-Eldering; Huibert Burger; Esther A E Holthausen; André Aleman; Willem A Nolen
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

4.  TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder.

Authors:  C E Millett; J Harder; J J Locascio; M Shanahan; G Santone; R N Fichorova; A Corrigan; C Baecher-Allan; K E Burdick
Journal:  Brain Behav Immun       Date:  2020-04-06       Impact factor: 7.217
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.